India and Seychelles have taken a significant step forward in healthcare and pharmaceutical collaboration by expanding their partnership under the Sesel Joint Vision framework. The updated agreement, formalized during high-level talks in early 2026, emphasizes sustainable healthcare development for Seychelles while deepening India’s role as a reliable partner in the Indian Ocean region.

Key areas of cooperation include: Capacity building Training programs for Seychellois doctors, nurses, and technicians in Indian medical institutions. Medicine and vaccine access Continued supply of affordable generic drugs, essential medicines, and vaccines from India. Telemedicine & digital health  Establishment of telemedicine links connecting Seychelles hospitals with Indian super-specialty centers for remote consultations and second opinions. Pharma & research collaboration Joint initiatives in pharmaceutical production, tropical disease research, and public health surveillance.

The partnership builds on India’s longstanding support to Seychelles, including donation of medical equipment, emergency medical teams during crises, and supply of COVID-19 vaccines under the Vaccine Maitri initiative. Seychelles, with its small population and island geography, faces challenges in maintaining a robust healthcare system and accessing specialized care. India’s expertise in cost-effective generics, large-scale vaccine manufacturing, and digital health platforms offers practical solutions.

Both nations highlighted mutual benefits: Seychelles gains stronger healthcare resilience and self-sufficiency, while India advances its strategic outreach in the Indian Ocean Region and promotes its pharmaceutical and digital health capabilities globally.